Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitecatabasispharma.com
Twitter@CatabasisPharma
CategoryBioTech
Phone617-349-1971
Emailinfo@catabasispha...
Employees
Founded2008

Offices

Cambridge, USA
19 Blackstone Street
Cambridge, MA, 02139
USA

People

CEO
Senior Vice President, Product Development and Regulatory Affairs

Funding

TOTAL $103M
FUNDING TOTAL $103M
Series A, 4/2010
SV Life Sciences
Clarus Ventures
MedImmune Ventures
Advanced Technology Ventures
$39M
Series A, 12/2010
$14.5M
Series A, 12/2011
SV Life Sciences
Clarus Ventures
MedImmune Ventures
Advanced Technology Ventures
$8M
Grant, 4/2012
$120k
Venture Round, 2/2013
SV Life Sciences
Clarus Ventures
MedImmune Ventures
Advanced Technology Ventures
$9M
Series B, 11/2013
Lightstone Ventures
SV Life Sciences
Clarus Ventures
MedImmune Ventures
Advanced Technology Ventures
$32.4M
DEBT TOTAL $4.09M
Debt, 1/2010
$2.09M
Debt, 1/2010
$2M

Tags

Catabasis Pharmaceuticals

Catabasis Pharmaceuticals, Inc. is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. There platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of novel mechanism of action therapies to safely and effectively treat inflammatory diseases.

Recent Milestones

Videos

Screenshots

Catabasis Pharmaceuticals screenshot
Above: Home Page
Uploaded: 1/20/10

Sources

  1. SEC (sec.gov) [edit]
  2. Catabasis Pharma pulls in $2M (masshightech.com) [edit]
  3. Catabasis lands $39M Series A for diabetes programs (fiercebiotech.com) [edit]
  4. Catabasis lands $14.5M tranche for Omega-3 drug development (fiercebiotech.com) [edit]
  5. Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing (catabasispharma.com) [edit]
  6. Catabasis gets $120K from MDA to test compounds (masshightech.com) [edit]
  7. Catabasis raises $9M for PhII-ready drug development program (fiercebiotech.com) [edit]
  8. Catabasis Pharmaceuticals Completes $32.4M Series B Financing (finsmes.com) [edit]
Edit This Page
Last Edited 12/2/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy